.AstraZeneca has shared a very early take a look at the efficiency of its internal antibody-drug con...
.After declaring a stage 3 launch based upon positive midstage outcomes, iTeos and GSK are actually ...
.The FDA ought to be actually more available and also collaborative to let loose a surge in approval...
.It's an uncommonly occupied Friday for biotech IPOs, along with Zenas BioPharma, MBX and also Bicar...
.Atea Pharmaceuticals' antiviral has actually stopped working one more COVID-19 trial, but the biote...
.Neurocrine Biosciences' mental illness program pivot has fallen short. The biotech was unable to re...
.Sanofi has created a late entrance to the radioligand celebration, paying for 100 million europeans...
.After F2G's first try to obtain a new course of antifungal to market was actually thwarted due to t...
.Moderna has vowed to reduce R&D spending through $1.1 billion by 2027. The selection to retract ...
.Just 4 months after Sanofi wager $80 thousand in ahead of time money on Fulcrum Rehabs' losmapimod,...